Dr. Steven G. DuBois, MD, MS
Claim this profileDana-Farber Cancer Institute
Studies Sarcoma
Studies Tumors
13 reported clinical trials
20 drugs studied
Area of expertise
1Sarcoma
Stage IV
RET positive
APC negative
2Tumors
NTRK positive
Stage IV
NTRK1 positive
Affiliated Hospitals
Clinical Trials Steven G. DuBois, MD, MS is currently running
CBL0137
for Cancer
This trial tests CBL0137, a drug that blocks signals inside cancer cells, in patients whose solid tumors, including CNS tumors or lymphoma, have returned or not responded to treatment. By interfering with the cells' internal communication, the drug aims to stop their growth and cause them to die. CBL0137, also known as Curaxin, has shown antitumor activity in multiple cancers, including glioblastoma, renal cell carcinoma, melanoma, neuroblastoma, and small cell lung cancer.
Recruiting1 award Phase 1 & 213 criteria
Ribociclib + Topotecan + Temozolomide
for Neuroblastoma
This is a Phase I/II study to assess the efficacy and safety of ribociclib in combination with topotecan and temozolomide (TOTEM) in pediatric patients with relapsed or refractory (r/r) neuroblastoma (NB), and other solid tumors, including medulloblastoma (MB), high-grade glioma (HGG), malignant rhabdoid tumors (MRT), and rhabdomyosarcoma (RMS).
Recruiting2 awards Phase 1 & 2
More about Steven G. DuBois, MD, MS
Clinical Trial Related2 years of experience running clinical trials · Led 13 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Steven G. DuBois, MD, MS has experience with
- Topotecan
- Cyclophosphamide
- Temozolomide
- Seclidemstat
- Cabozantinib
- Myeloid Growth Factor
Breakdown of trials Steven G. DuBois, MD, MS has run
Sarcoma
Tumors
Solid Tumors
Ewing Sarcoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Steven G. DuBois, MD, MS specialize in?
Steven G. DuBois, MD, MS focuses on Sarcoma and Tumors. In particular, much of their work with Sarcoma has involved Stage IV patients, or patients who are RET positive.
Is Steven G. DuBois, MD, MS currently recruiting for clinical trials?
Yes, Steven G. DuBois, MD, MS is currently recruiting for 6 clinical trials in Boston Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Steven G. DuBois, MD, MS has studied deeply?
Yes, Steven G. DuBois, MD, MS has studied treatments such as Topotecan, Cyclophosphamide, Temozolomide.
What is the best way to schedule an appointment with Steven G. DuBois, MD, MS?
Apply for one of the trials that Steven G. DuBois, MD, MS is conducting.
What is the office address of Steven G. DuBois, MD, MS?
The office of Steven G. DuBois, MD, MS is located at: Dana-Farber Cancer Institute, Boston, Massachusetts 02215 United States. This is the address for their practice at the Dana-Farber Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.